Teva Targeted Over Alleged US Nuvigil-EpiPen Conspiracy

Follows Combined $600m Settlements Signed By Mylan, Pfizer

Antitrust law - Image
Teva was sued over its ANDA in 2009 • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Legal & IP

More from Generics Bulletin